Introduction
Over 10 years ago, while studying the topology and mode of anchorage of angiotensin-converting enzyme (ACE) in brush border membranes of pig kidney, we observed that a substantial portion of the ACE activity was released in a tirnedependent manner into the soluble supernatant fraction after centrifugation [ 11. This solubilized ACE activity was hydrophilic and could not reconstitute into lipid vesicles, having, we presumed, lost its transmembrane anchor through a proteolytic event in the membrane. We subsequently referred to this cleavage activity as a 'membrane protein secretase'; ACE secretase is now the prototype of a family of proteinases that cause the release (or 'shedding') of certain membrane proteins, normally from the cell surface into the extracellular milieu [2] . Proteins shed in this fashion include some membrane receptors and receptor ligands, ectoenzymes and cell adhesion molecules (see Table 1 for Abbreviations used: ACE, angiotensin-converting enzyme; ADAM'TS-1, ADAM protein with thrombospondin motif; APP, amyloid precursor protein; MADM, mammalian disintegrin-metalloproteinase; MMP, matrix metalloproteinase; PAR, proteinase-activated receptor; 'I'ACE, TNF-a-converting enzyme; TNF, tumour necrosis factor. ' To whom correspondence should be addressed. examples and [2] for a more complete listing.) Shedding normally involves cleavage at a single, unique site in the membrane protein. However, there are examples in which cleavage at more than one site occurs to generate the released peptide or protein, e.g. in the release of the amyloid /j protein from the amyloid precursor protein (APP) [2, 3] or in the two-step cleavage of the sterol regulatory element-binding protein, an event occurring in the endoplasmic reticulum [4] . There are also examples in which specific proteolytic cleavage can modify the activity of a membrane receptor without its release from the cell surface. This is seen with the proteinaseactivated G-protein-linked receptors such as the thrombin receptor [proteinase-activated receptor 1 (PAR-l)] [S] and the more recently described PAR-2 and PAR-3 [6] . Here, cleavage at specific sites in the N-terminal extracellular portion of the receptor triggers receptor activation irreversibly. The Dmsophilu protein Kuzbanian also functions in the processing of a cell-surface receptor (Notch) to its functionally competent form for signalling during development [ 7, 8] .
Many of the membrane protein secretases are susceptible to inhibition by metal-chelating agents and, more specifically, by certain hydroxamic acid-based compounds such as batimastat [Z] , suggesting that they are zinc metalloproteinases (see Table 1 ). Because the secretases often 
The ADAM protein family
The ADAM ('a disintegrin and metalloproteinase-like') family (otherwise known as the adamalysin family) is a large and expanding group of mammalian membrane-bound proteins (Table 2 ; reviewed in . T h e ADAM proteins have structural similarity to certain snake venom metalloproteinases, the 'reprolysins', of which the atrolysins are the best characterized [12] . So far over 20 full-length ADAM cDNA species have been reported [10, 13] . They are normally characterized by the presence of a proteolytic domain, an adhesion (disintegrin) domain and a signalling domain. Some of the family members have a fusion domain and/or an epidermal growth factor-like domain. The proteinase domain contains a typical extended zinc-binding site with a conserved aspartate residue, which is a signature for reprolysin family members. For most ADAM proteinases their physiological substrates are unknown. It should be noted that, in some members of the ADAM family, critical residues involved in zinc binding or catalysis are not conserved (Table 2 ). These members are therefore unlikely to be catalytically Although most ADAM members contain a potential membrane-spanning region located near the C-terminus, and are therefore at least initially membrane-bound, a soluble ADAM protein has recently been described [15] . The cDNA encoding ADAMTS-1 (ADAM protein with thrombospondin motif) was isolated from a colon adenocarcinoma cell line. The encoded protein possesses a prodomain, a metalloproteinase domain, a disintegrin-like domain and a thrombospondin type I domain. The protein is secreted from the cell and anchors at the extracellular matrix through its thrombospondin motif [16] . ADAMTS-1 mRNA was induced by stimulating cells with the inflammatory cytokine interleukin 1 and by intravenous administration of lipopolysaccharide, suggesting that ADAMTS-1 might be a gene whose expression is associated with certain inflammatory responses.
Activation of ADAM proteinases is presumed to occur via a 'cysteine-switch' mechanism in which a critical cysteine residue near the C-terminus of the prodomain interacts with the active-site zinc, maintaining it in a catalytically inactive state as in the matrix metalloproteinases (MMPs) [lo] . Proteolytic removal of the prodomain at a furin consensus site would then lead to activation of the enzyme. This mechanism has recently been shown to operate for human ADAM12 (meltrin x ) [ 171. 'The disintegrin-like adhesion domain of these proteins might interact with integrin-like receptors on adjacent cells to promote cell-cell interactions, or could disrupt interactions between integrin receptors and the ~4 1 . extracellular matrix. It is unknown whether the disintegrin domain modulates proteolytic activity; domain-switching experiments could be used to explore this possibility, as well as the roles of the potential signalling domains of ADAM proteins.
Two mammalian ADAM-family proteinases: ADAM I 0 and TACE
Two members of the ADAM family that have provided insight into their possible physiological roles are ADAM10 and TACE. In 1989, Glynn and co-workers purified a metalloproteinase from bovine brain that was capable of degrading myelin basic protein [ 181. Subsequent isolation and sequencing of its cDNA revealed that it was a member of the ADAM family and the enzyme was referred to as MADM (mammalian disintegrin-metalloproteinase; ADAM10) [ 191. This provided the first definitive proof that ADAM family members could act as proteinases. Whether myelin basic protein is a true physiological substrate for MADM is still not clear.
Tumour necrosis factor a (TNF-a) is a cytokine that contributes to a variety of inflammatory disease states. TNF-x is cleaved from its transmembrane precursor through the action of a zinc metalloproteinase known as TNF-x convertase (TACE). Recently, TACE was isolated and cloned [20, 21] , revealing it to be a member of the mammalian ADAM family. The cDNA encodes a protein of 824 residues, consisting of a multidomain extracellular region, a transmembrane helix and an intracellular C-terminal tail containing potential phosphorylation sites and an SH3-binding site (Figure 1 ). The N-terminal region has a prodomain with a 'cysteine switch' and a furin cleavage site, a catalytic domain typical of the metzincin metalloproteinases [22] , followed by a Cys-rich region comprising elements of a disintegrin-like domain, an epidermal growth factor-like domain and a crambin-like domain. T h e possible activation of the enzyme by furin-catalysed removal of its prodomain is consistent with previous observations that serine proteinase inhibitors can prevent the release of soluble TNF-a from cells [23] . T h e active-site region of TACE has been modelled on the basis of the structure of adamalysin I1 [24] and, more recently, a 2 A resolution crystal structure of the catalytic domain of TACE itself has proved highly informative [25] . It reveals unique surface features distinct from the known adamalysin structures as well as unique features in the active-site pocket that should aid in the design of selective TACE in hi hi tors. Interestingly, ADAM10 has recently been shown to cleave a peptide substrate spanning the authentic cleavage site in proTNF [26] and might therefore also be able to function as a TACE.
TACE is distinct from ACE secretase and APPor-secretase
T h e release of a wide range of cell-surface proteins, including T N F receptors, L-selectin, Fas ligand, interleukin 6 receptor, ACE and APP, is blocked by hydroxamic acid-based zinc metalloproteinase inhibitors (such as batimastat) in a similar fashion to the inhibition of TACE (reviewed in [2] ), suggesting that TACE might participate in the shedding of multiple membrane proteins. T o explore the relationship between ACE secretase, M P r-secretase and TACE we have examined the ability of TACE to cause the release of ACE either from reconstituted lipid vesicles or from pig kidney brush border membranes and also coinpared the effects of known secretase inhibitors on these three activities [27] . T o assess whether TACE could act as an 'ICE secretase, purified pig kidney ACE was incorporated into artificial lipid vesicles [28] , which then served as a potential substrate for either recombinant extracellular domain TACE or natural full-length TACE. In neither case was any significant cleavage of ACE from the lipid vesicles observed [27] . However, trypsin caused substantial release of ACE into the medium. Similarly, TACE did not cause any increase in ACE release from kidney microvillar membranes over and above the endogenous ACE secretase activity. Again, exogenous trypsin produced substantial additional release of ACE. When the sensitivities of 'I'ACE, ,ACE secretase and the constitutive APP a-secretase to three hydroxyamate-based zinc metalloprotease inhibitors (batimastat, compound 1 and compound 4) [29] ) were compared, marked differences were observed between TACE on the one hand and ACE secretase and a-secretase on the other. All three compounds were at least two orders of magnitude more potent against TACE than against the other two secretases [27] . Taken together these results strongly suggest that TACE is distinct from, but possibly related to, ACE secretase and the constitutive a-secretase. This does not preclude TACE from participating in the regulated a-secretase pathway nor in the release of other membrane proteins. T o establish whether ACE secretase and APP r-secretase are also members of the ADAMs family of metalloproteinases will require their isolation and cloning.
Conclusion
T h e ability to act as membrane protein secretases might be a common feature of proteolytically active ADAM family members, allowing the release of soluble proteins that can mediate or inhibit cell-cell interactions, thereby influencing developmental, signalling or other events. It is now apparent that a detailed understanding of the biology of ADAM proteins has fundamental implications for both health and disease, with a priority being to identify the relevant substrates for the catalytically active family members and to design potent and selective inhibitors as potential the rape u tic s.
Note added in proof (received I 7 November 1998) Since submission of this manuscript, Buxbaum et al. [34] have shown that TACE is involved in the regulated (but not the constitutive) r-sccretase cleavage of MP. These data, however, were unable to distinguish between a direct or an indirect action of TACE on XPP cleavage. T h e report is consistent with our observation that the inhibitory profile of ACE secretase and the constitutive x-secretase is distinct from that of TIICE. 
